LGSN
geneOn this page
Also known as LGS
Summary
LGSN (lengsin, lens protein with glutamine synthetase domain, HGNC:21016) is a protein-coding gene on chromosome 6q12, encoding Lengsin (Q5TDP6). May act as a component of the cytoskeleton or as a chaperone for the reorganization of intermediate filament proteins during terminal differentiation in the lens.
This gene encodes a protein with similarity to the GS I members of the glutamine synthetase superfamily. The encoded protein is referred to as a pseudo-glutamine synthetase because it has no glutamine synthesis activity and may function as a chaperone protein. This protein is localized to the lens and may be associated with cataract disease. Alternative splicing results in multiple transcript variants.
Source: NCBI Gene 51557 — RefSeq curated summary.
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 101 total
- MANE Select transcript:
NM_016571
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21016 |
| Approved symbol | LGSN |
| Name | lengsin, lens protein with glutamine synthetase domain |
| Location | 6q12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | LGS |
| Ensembl gene | ENSG00000146166 |
| Ensembl biotype | protein_coding |
| OMIM | 611470 |
| Entrez | 51557 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 protein_coding
ENST00000370657, ENST00000370658, ENST00000485906, ENST00000622415
RefSeq mRNA: 2 — MANE Select: NM_016571
NM_001143940, NM_016571
CCDS: CCDS4964, CCDS55027
Canonical transcript exons
ENST00000370657 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002151654 | 63294913 | 63295045 |
| ENSE00002178279 | 63275951 | 63281220 |
| ENSE00002187861 | 63285587 | 63285753 |
| ENSE00003893550 | 63319914 | 63319983 |
Expression profiles
Bgee: expression breadth broad, 67 present calls, max score 82.01.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0497 / max 89.7447, expressed in 1 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 74200 | 0.0497 | 1 |
Top tissues by expression
252 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 82.01 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 75.95 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 68.23 | gold quality |
| right lobe of liver | UBERON:0001114 | 65.49 | gold quality |
| liver | UBERON:0002107 | 62.46 | gold quality |
| placenta | UBERON:0001987 | 59.82 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 52.07 | silver quality |
| bronchus | UBERON:0002185 | 51.63 | silver quality |
| bronchial epithelial cell | CL:0002328 | 51.59 | silver quality |
| adult mammalian kidney | UBERON:0000082 | 50.12 | gold quality |
| nephron tubule | UBERON:0001231 | 49.89 | silver quality |
| colonic epithelium | UBERON:0000397 | 49.68 | gold quality |
| kidney | UBERON:0002113 | 49.40 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 49.30 | gold quality |
| blood vessel layer | UBERON:0004797 | 49.29 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 49.20 | gold quality |
| hair follicle | UBERON:0002073 | 49.18 | gold quality |
| olfactory bulb | UBERON:0002264 | 48.92 | gold quality |
| choroid plexus epithelium | UBERON:0003911 | 48.89 | gold quality |
| myocardium | UBERON:0002349 | 48.87 | gold quality |
| type B pancreatic cell | CL:0000169 | 48.83 | gold quality |
| quadriceps femoris | UBERON:0001377 | 48.81 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 48.55 | gold quality |
| CA1 field of hippocampus | UBERON:0003881 | 48.50 | gold quality |
| vastus lateralis | UBERON:0001379 | 48.25 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 48.24 | gold quality |
| orbitofrontal cortex | UBERON:0004167 | 48.20 | gold quality |
| upper arm skin | UBERON:0004263 | 48.06 | gold quality |
| cervix epithelium | UBERON:0004801 | 48.04 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 47.92 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.90 |
| E-GEOD-99795 | no | 16.64 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
135 targeting LGSN, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-7110-3P | 100.00 | 73.18 | 2486 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-10401-5P | 99.99 | 65.79 | 948 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-4715-3P | 99.98 | 66.03 | 670 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-8068 | 99.98 | 73.85 | 2376 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-302E | 99.96 | 70.74 | 2669 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-23A-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23B-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23C | 99.95 | 73.92 | 3192 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-381-3P | 99.93 | 71.87 | 2854 |
| HSA-MIR-338-5P | 99.92 | 72.34 | 2951 |
| HSA-MIR-300 | 99.92 | 71.76 | 2856 |
| HSA-MIR-8063 | 99.91 | 69.76 | 3146 |
| HSA-MIR-3671 | 99.90 | 73.04 | 3897 |
Literature-anchored findings (GeneRIF, showing 5)
- Lengsin is major novel protein of the vertebrate eye lens. (PMID:12107413)
- A potential chaperone-like role of Lengsin was investigated. (PMID:17010935)
- Lengsin belongs to the predominantly prokaryotic class 1 branch of glutamine synthetases but has lost enzyme activity (PMID:17161372)
- Novel spliced form of a lens protein as a novel lung cancer antigen, Lengsin splicing variant 4, is reported. (PMID:19459848)
- In major depressive disorder genome-wide association study, best male-specific SNP was rs9362774 within LGSN gene (PMID:21621269)
Cross-species orthologs
7 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | lgsn | ENSDARG00000007715 |
| mus_musculus | Lgsn | ENSMUSG00000050217 |
| rattus_norvegicus | Lgsn | ENSRNOG00000012205 |
| caenorhabditis_elegans | WBGENE00001602 | |
| caenorhabditis_elegans | WBGENE00001604 | |
| caenorhabditis_elegans | WBGENE00001606 | |
| caenorhabditis_elegans | WBGENE00001607 |
Paralogs (1): GLUL (ENSG00000135821)
Protein
Protein identifiers
Lengsin — Q5TDP6 (reviewed: Q5TDP6)
Alternative names: Glutamate-ammonia ligase domain-containing protein 1, Lens glutamine synthase-like
All UniProt accessions (2): Q5TDP6, A0A0A0MTD2
UniProt curated annotations — full annotation on UniProt →
Function. May act as a component of the cytoskeleton or as a chaperone for the reorganization of intermediate filament proteins during terminal differentiation in the lens. Does not seem to have enzymatic activity.
Subunit / interactions. Dodecamer. Interacts with BFSP2 and VIM.
Tissue specificity. Abundantly expressed in lens.
Similarity. Belongs to the glutamine synthetase family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5TDP6-1 | 1, LGS_v2 | yes |
| Q5TDP6-2 | 2, LGS_v1 | |
| Q5TDP6-3 | 3, LGS_v3 |
RefSeq proteins (2): NP_001137412, NP_057655* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR008146 | Gln_synth_cat_dom | Domain |
| IPR008147 | Gln_synt_N | Domain |
| IPR014746 | Gln_synth/guanido_kin_cat_dom | Homologous_superfamily |
| IPR036651 | Gln_synt_N_sf | Homologous_superfamily |
Pfam: PF00120
UniProt features (13 total): splice variant 4, sequence variant 3, domain 2, sequence conflict 2, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5TDP6-F1 | 77.35 | 0.53 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 82 (showing top):
GOBP_GLUTAMINE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS, chr6q12, GOBP_ALPHA_AMINO_ACID_METABOLIC_PROCESS, GOBP_AMINO_ACID_BIOSYNTHETIC_PROCESS, GOBP_GLUTAMINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS, CAGCTG_AP4_Q5, GOBP_ORGANIC_ACID_BIOSYNTHETIC_PROCESS, GOBP_GLUTAMINE_METABOLIC_PROCESS, GOBP_SMALL_MOLECULE_BIOSYNTHETIC_PROCESS, GATA6_01, TGACATY_UNKNOWN, GOBP_ORGANIC_ACID_METABOLIC_PROCESS, HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP, GOMF_LIGASE_ACTIVITY_FORMING_CARBON_NITROGEN_BONDS, TGGAAA_NFAT_Q4_01
GO Biological Process (1): obsolete glutamine biosynthetic process (GO:0006542)
GO Molecular Function (2): catalytic activity (GO:0003824), glutamine synthetase activity (GO:0004356)
GO Cellular Component (3): cytoplasm (GO:0005737), plasma membrane (GO:0005886), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| molecular_function | 1 |
| ammonia ligase activity | 1 |
| intracellular anatomical structure | 1 |
| membrane | 1 |
| cell periphery | 1 |
Protein interactions and networks
STRING
2587 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| LGSN | GLUL | P15104 | 940 |
| LGSN | CRYBA4 | P53673 | 586 |
| LGSN | BFSP2 | Q13515 | 580 |
| LGSN | BFSP1 | Q12934 | 570 |
| LGSN | KHDRBS2 | Q5VWX1 | 557 |
| LGSN | GRIFIN | A4D1Z8 | 532 |
| LGSN | NOXRED1 | Q6NXP6 | 529 |
| LGSN | CRYZL1 | O95825 | 519 |
| LGSN | SMAP1 | Q8IYB5 | 507 |
| LGSN | CRYBB1 | P53674 | 500 |
| LGSN | CRYGN | Q8WXF5 | 491 |
| LGSN | CRYBA2 | P53672 | 490 |
| LGSN | LIM2 | P55344 | 475 |
| LGSN | MIP | P30301 | 472 |
| LGSN | CRYGD | P07320 | 464 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| YBX1 | HNRNPR | psi-mi:“MI:0915”(physical association) | 0.770 |
| NEK4 | E2F8 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (3): LGSN (Co-fractionation), LGSN (Affinity Capture-MS), LGSN (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A0JM23, A2RSY6, A6H6X4, A6H8I2, A6NNW6, O60502, O93511, P0CI65, P41320, Q008S8, Q0GA40, Q14AW5, Q1ZZS1, Q2TBM9, Q3U213, Q3UH60, Q496Z9, Q4R3G4, Q4R6C7, Q5R5T0, Q5TDP6, Q692V3, Q6AZT7, Q6K3T2, Q6NVJ5, Q6P2S7, Q6P3V7, Q6P6R7, Q6UXZ4, Q7T2D0, Q7TT51, Q7Z2T5, Q8CIX8, Q8GYY7, Q8TEU7, Q8VIJ5, Q96524, Q96JX3, Q99MV7, Q9BXT8
Diamond homologs: A0R079, I3R176, O08467, O27612, O29313, O58097, O59648, O66514, O87393, P00964, P05457, P07804, P09826, P0A039, P0A040, P0A1P6, P0A1P7, P0A591, P0A9C5, P0A9C6, P0A9C7, P0A9C8, P0C7B6, P10583, P10656, P12425, P13499, P15106, P15124, P19064, P19904, P20805, P21154, P22248, P23794, P25821, P28605, P28786, P31592, P33035
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
101 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 86 |
| Likely benign | 9 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1075 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:63285585:A:AC | donor_gain | 1.0000 |
| 6:63285586:C:CC | donor_gain | 1.0000 |
| 6:63294929:AT:A | donor_gain | 1.0000 |
| 6:63294976:T:A | donor_gain | 1.0000 |
| 6:63294979:T:TA | donor_gain | 1.0000 |
| 6:63293852:CCTCT:C | acceptor_gain | 0.9900 |
| 6:63293853:CTCT:C | acceptor_gain | 0.9900 |
| 6:63293853:CTCTC:C | acceptor_gain | 0.9900 |
| 6:63293854:TCTCT:T | acceptor_gain | 0.9900 |
| 6:63293855:CT:C | acceptor_gain | 0.9900 |
| 6:63293857:C:CC | acceptor_gain | 0.9900 |
| 6:63294869:G:A | donor_gain | 0.9900 |
| 6:63294945:T:TA | donor_gain | 0.9900 |
| 6:63295056:T:TC | acceptor_gain | 0.9900 |
| 6:63295491:CCTTA:C | acceptor_gain | 0.9900 |
| 6:63295493:T:C | acceptor_gain | 0.9900 |
| 6:63295495:A:C | acceptor_gain | 0.9900 |
| 6:63295975:AGTAT:A | donor_gain | 0.9900 |
| 6:63319912:ACCT:A | donor_gain | 0.9900 |
| 6:63319913:CCTC:C | donor_gain | 0.9900 |
| 6:63319915:T:TA | donor_gain | 0.9900 |
| 6:63285754:C:CC | acceptor_gain | 0.9800 |
| 6:63293854:TCT:T | acceptor_gain | 0.9800 |
| 6:63293855:CTC:C | acceptor_gain | 0.9800 |
| 6:63293855:CTCT:C | acceptor_loss | 0.9800 |
| 6:63293856:TCT:T | acceptor_gain | 0.9800 |
| 6:63293857:CT:C | acceptor_loss | 0.9800 |
| 6:63293858:T:A | acceptor_loss | 0.9800 |
| 6:63294930:T:C | donor_gain | 0.9800 |
| 6:63294980:C:A | donor_gain | 0.9800 |
AlphaMissense
3388 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:63285651:C:G | R89P | 0.994 |
| 6:63280306:G:C | N415K | 0.993 |
| 6:63280306:G:T | N415K | 0.993 |
| 6:63280521:A:G | W344R | 0.993 |
| 6:63280521:A:T | W344R | 0.993 |
| 6:63281041:A:C | C170W | 0.991 |
| 6:63285654:A:T | V88E | 0.990 |
| 6:63281043:A:G | C170R | 0.989 |
| 6:63280271:C:T | G427D | 0.988 |
| 6:63280483:G:C | S356R | 0.988 |
| 6:63280483:G:T | S356R | 0.988 |
| 6:63280485:T:G | S356R | 0.988 |
| 6:63285611:C:A | K102N | 0.988 |
| 6:63285611:C:G | K102N | 0.988 |
| 6:63285643:C:G | A92P | 0.988 |
| 6:63285616:A:G | S101P | 0.987 |
| 6:63280508:A:G | L348P | 0.986 |
| 6:63281042:C:T | C170Y | 0.986 |
| 6:63285648:A:G | F90S | 0.986 |
| 6:63280997:C:A | R185M | 0.985 |
| 6:63281099:G:C | P151R | 0.983 |
| 6:63280274:G:T | A426D | 0.982 |
| 6:63280278:C:G | A425P | 0.982 |
| 6:63281048:A:T | V168E | 0.982 |
| 6:63281099:G:T | P151Q | 0.982 |
| 6:63280997:C:G | R185T | 0.981 |
| 6:63280967:A:G | L195P | 0.980 |
| 6:63281054:G:T | A166E | 0.980 |
| 6:63285636:T:A | D94V | 0.980 |
| 6:63280715:G:T | A279D | 0.979 |
dbSNP variants (sampled 300 via entrez): RS1000013411 (6:63494193 G>A,T), RS1000023914 (6:63523524 T>C), RS1000028040 (6:63481101 T>A,C), RS1000041265 (6:63392072 G>C), RS1000044776 (6:63414448 T>A,C), RS1000048089 (6:63454534 G>A), RS1000069601 (6:63378208 G>A), RS1000070053 (6:63469385 A>G), RS1000072605 (6:63500096 C>A), RS1000073611 (6:63337097 G>A), RS1000100161 (6:63532841 A>C), RS1000121016 (6:63504462 G>C), RS1000121441 (6:63378515 T>C), RS1000130102 (6:63557357 G>A), RS1000141490 (6:63433567 C>T)
Disease associations
OMIM: gene MIM:611470 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001762_641 | Obesity-related traits | 5.000000e-06 |
| GCST004735_25 | Epstein-Barr virus copy number in lymphoblastoid cell lines | 4.000000e-07 |
| GCST009391_76 | Metabolite levels | 9.000000e-06 |
| GCST90000050_54 | Age at first birth | 3.000000e-08 |
| GCST90014325_1 | Asthma | 6.000000e-09 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009101 | age at first birth measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases expression, decreases methylation | 2 |
| 2-methyl-4-isothiazolin-3-one | decreases expression | 1 |
| sulforaphane | decreases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| dinophysistoxin 1 | decreases expression | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| abrine | increases expression | 1 |
| licochalcone B | decreases expression | 1 |
| Cadmium | decreases expression | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Quercetin | decreases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Asbestos, Crocidolite | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Copper Sulfate | increases expression | 1 |
| Vitamin K 3 | affects expression | 1 |
| Particulate Matter | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_D7TK | Ubigene A-549 LGSN KO | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): Epstein-Barr virus infection